2322 (2322) Fair Value & Analysis

Industrials · Market cap HK$346M

2 2322 2322 · HK

PriceHK$0.0860

Fair ValueHK$0.1600

Upside+86.0%

Quality42/100

Watch 2322 for free — get notified when fair value or trend changes. Watch for free

Evidence: Low Range HK$0.0860 – HK$0.2417

Fair value as of: Jul 2, 2026

From 3 valuation models · updated today

Share price −7.5% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.0820 – HK$0.4350 · fair‑value band HK$0.0860 – HK$0.2417 · the HK$0.0860 price screens below the HK$0.1600 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

2322 (2322) currently trades at HK$0.0860, while our model-based Fair Value estimate is HK$0.1600 — implying the stock looks roughly 86.0% undervalued today. We read business quality at 42/100 (below-average quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

Trailing-twelve-month revenue stands at HK$68.1M. Revenue declined 15.7% year over year. It earns a return on equity of -12.3%. The balance sheet holds a net cash position of HK$58.1M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$68.1M

Revenue growth (YoY) -15.7%

Net margin -120%

Return on equity -12.3%

Free cash flow −HK$61.7M FY2025

Operating margin -80.8%

More key figures

EPS (TTM) HK$-0.0200

Net cash HK$58.1M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

2322 reported revenue of HK$73.7M in FY2025 versus HK$338M in FY2021, a compound −31.7%/yr. Reported net income was −HK$89.0M in FY2025.

Revenue −31.7%/yr

FY21 HK$338M

FY22 HK$169M

FY23 HK$199M

FY24 HK$145M

FY25 HK$73.7M

Net income

FY21 −HK$23.2M

FY22 −HK$26.8M

FY23 −HK$41.7M

FY24 −HK$87.4M

FY25 −HK$89.0M

Is 2322 fairly valued? → Check now

Similar stocks

6 more Conglomerates stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Honeywell International Inc HON	C$25.91	C$16.17	-38%
CITIC Limited 0267	HK$13.62	HK$22.20	+63%
0019 0019	HK$81.70	HK$13.77	-83%
CK Hutchison Holdings 0001	HK$66.25	HK$118.82	+79%
Itaúsa S.A ITSA3	R$13.05	R$13.52	+4%
SK Inc 034730	625,000 KRW	390,279 KRW	-38%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 2322 (2322) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.1600 versus a price of HK$0.0860 — about +86% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 2322?

Our model-based fair value for 2322 is HK$0.1600 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.0860.

What is the quality score of 2322?

2322 has a Quality Score of 42/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 2322 (2322)?

2322 reported trailing-twelve-month revenue of about HK$68.1M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 2322?

The net profit margin of 2322 is about -120.3%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.